Objective: The aim was to evaluate a group treatment for people with multiple sclerosis and low mood.
Design: Randomized controlled trial.
Setting: Community.
Participants: Patients with multiple sclerosis and low mood, scoring >7 on the Hospital Anxiety and Depression Scales or >2 on the General Health Questionnaire 12.
Interventions: Participants either attended an adjustment group for six, 2-hour group treatment sessions or were on a waiting list to attend the group.
Outcomes: Hospital Anxiety and Depression Scale, General Health Questionnaire 12, Multiple Sclerosis Self Efficacy Scale, Multiple Sclerosis Impact Scale and Short Form 36 administered 3 and 6 months after random allocation.
Results: Of the 219 patients identified, 100 (46%) reported depressive symptoms and 126 (58%) anxiety symptoms. Forty participants were recruited, aged 25—68 (mean 47.7 SD 9.7) and eight were men. Patients allocated to the group intervention reported fewer depressive symptoms than those in the control group (U 109.5, P<0.05) but there were no significant differences in anxiety symptoms, self-efficacy or quality of life.
Conclusion: Depressive symptoms were reduced following group intervention, which suggests this may be an effective psychological treatment and warrants further evaluation.
Get full access to this article
View all access options for this article.
References
1.
Goldman Consensus Group.The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler2005; 11: 328-37.
2.
Lobentanz IS , Asenbaum S., Vass K. et al. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand2004; 110: 6.
3.
Solari A., Ferrari G., Radice D.A longitudinal survey of self-assessed health trends in a community cohort of people with multiple sclerosis and their significant others. J Neurol Sci2005; 243: 13-20.
4.
McGuigan C., Hutchinson M.Unrecognised symptoms of depression in a community-based population with multiple sclerosis. J Neurol2005; 253: 219-23.
5.
Mohr DC, Hart SL, Fonareva I., Tasch ESTreatment of depression for patients with multiple sclerosis in neurology clinics. Mult Scler2006; 12: 204-208.
6.
Zephir H., De Seze J., Stojkovic T. et al. Multiple sclerosis and depression: influence of interferon <beta> therapy. Mult Scler2003; 9: 284-88.
7.
Arnett PA, Randolph JJLongitudinal course of depression symptoms in multiple sclerosis. J Neurol Neurosurg Psychiatry2006; 77: 606-10.
8.
Alarcia R., Ara JR, Martin J., Bertol V.Predicting factors for depression in multiple sclerosis. Neurologia2004; 19: 364-68.
9.
Diaz-Olavarrieta C., Cummings JL, Velazquez J., Garcia de la Cadena C.Neuropsychiatric manifestations of multiple sclerosis. J Neuropsychiatry Clin Neurosci1999; 11: 51-57.
10.
Korostil M. , Feinstein A.Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler2007; 13: 67-72.
11.
Feinstein A. , O’Connor P., Gray T., Feinstein K.The effects of anxiety on psychiatric morbidity in patients with multiple Sclerosis. Mult Scler1999; 5: 323-26.
12.
Janssens ACJ , van Doorn PA, de Boer JB et al. Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurol Scand2003; 108: 389-95.
13.
Crayton HJ, Rossman HSManaging the symptoms of multiple sclerosis: A multimodal approach . Clin Ther2006; 28: 445-60.
14.
Feinstein A.Mood disorders in multiple sclerosis and the effects on cognition. J Neurol Sci2006 ; 245: 63-66.
15.
Mohr DC, Goodkin DETreatment of depression in multiple sclerosis: review and meta-analysis . Clin Psychol Sci Pract1999; 6: 1-9.
16.
Wang JL, Rreimer MA, Metz LM, Patten SBMajor depression and quality of life in individuals with multiple sclerosis . Int J Psychiatry Med2000; 30: 309-17.
17.
D’Alisa S., Miscio G., Baudo S., Simone A., Tesio L., Mauro A.Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study. Disabil Rehabil2006; 28: 307-14.
18.
Simmons RD, Ponsonby AL, van der Mei IAF, Sheridan P.What affects your MS? Responses to an anonymous, Internet-based epidemiological survey. Mult Scler2004; 10: 202-11.
19.
Ackerman KD , Rabin B., Heyman R., Anderson BP, Houch PR, Frank E.Stressful life events precede multiple sclerosis disease exacerbations. Psychosom Med2000 ; 62: 147.
20.
Potagas C. , Mitsonis C., Watier L. et al. Influence of anxiety and reported stressful life events on relapses in multiple sclerosis: a prospective study. Mult Scler2008; 14: 1262-68.
21.
Minden SLMood disorders in multiple sclerosis: diagnosis and treatment. J Neurovirol2000; 6: S160-67.
22.
Minden SL , Orav J., Reich P.Depression in multiple sclerosis. Gen Hosp Psychiatry1987; 9: 426-34.
23.
Feinstein A.An examination of suicidal intent in patients with multiple sclerosis. Neurology2002; 59: 674-78.
24.
Thomas PW, Thomas S., Hillier C., Galvin K., Baker R.Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev2006; (1): CD004431.
25.
Larcombe NA , Wilson PHAn evaluation of cognitive-behaviour therapy for depression in patients with multiple sclerosis. Br J Psychiatry1984; 145: 366-71.
26.
Mohr DC, Likosky W., Bertagnolli A. et al. Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. J Consult Clin Psychol2000; 68: 356-61.
27.
Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A., Epstein L.Comparative outcomes for individual cognitive-behaviour therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol2001; 69: 942-49.
28.
Foley FW, Bedell JR, LaRocca NG, Scheinberg LC, Reznikoff M.Efficacy of stress-inoculation training in coping with multiple sclerosis . J Consult Clin Psychol1987; 55: 919-22.
29.
Rigby, S.Coping with multiple sclerosis. Unpublished PhD thesis, University of Liverpool, Liverpool, UK, 2003.
30.
Wassem R., Dudley W.Symptom management and adjustment of patients with multiple sclerosis . Clin Nurs Res2003; 12: 102-17.
31.
Hart S., Fonareva I., Merluzzi N., Mohr DCTreatment for depression and its relationship to improvement in quality of life and psychological well-being in multiple sclerosis patients. Qual Life Res2005; 14: 695-703.
32.
Peters T., Somerset M., Campbell R., Sharp D.Variables associated with attendance at, and the perceived helpfulness of, meetings for people with multiple sclerosis. Health Soc Care Community2003; 11: 19-26.
33.
Forman A., Vesey P., Lincoln N.Effectiveness of an adjustment group for brain injury patients: a pilot evaluation . Int J Ther Rehabil2006 ; 13: 223-28.
34.
Maguire BLThe effects of imagery on attitude and moods in multiple sclerosis patients . Altern Ther Health Med1996; 2: 75-79.
Goldberg D.General Health Questionnaire (GHQ-12) . Windsor: NFER-Nelson, 1992.
37.
Nicholl CR, Lincoln NB, Francis VMAssessment of emotional problems in people with multiple sclerosis . Clin Rehabil2001; 15: 657-68.
38.
Hobart J., Riazi A., Lamping D., Fitzpatrick R., Thompson A.How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales. J Neurol Neurosurg Psychiatry2005; 76: 1539-43.
39.
Sharrack B. , Hughs RAThe Guy’s Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Mult Scler1999; 5: 223-33.
40.
Townsend S.Regaining confidence after stroke: a manual for group leaders. Shropshire Enablement Team, 2003.
41.
Hobart J., Lamping D., Fitzpatrick R., Riazi A., Thompson A.The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain2001; 124: 962-73.
42.
Domenech CL , Thornton EW, Young CA, Rigby SA, Tedman S.Development of a self-efficacy scale for people with multiple sclerosis. Mult Scler1999; 5: S144.
43.
Ware JE, Snow KK, Kosinski M., Gandek B.SF-36 Health survey manual and interpretation guide. Boston, MA, Nimrod Press, 1993.
44.
Riazi A., Hobart J., Lamping D., Fitzpatrick R., Thompson A.Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. J Neurol Neurosurg Psychiatry2002; 73: 701-704.
45.
Shnek ZM, Foley FW, LaRocca NG, Smith CR, Halper J.Psychological predictors of depression in multiple sclerosis. J NeuroRehabil1995; 9: 15-23.
46.
Matthews JNS , Altman DG, Campbell MJ, Royston P.Analysis of serial measurements in medial research. BMJ1990; 300: 230-35.
47.
Crawford J. , McIvor G.Group psychotherapy: benefits in multiple sclerosis. Arch Phys Med Rehabil1985; 66: 810-13.
48.
Tesar N., Baumhackl U., Kopp M., Günther V.Effects of psychological group therapy inpatients with multiple sclerosis . Acta Neurol Scand2003; 107: 393-99.
